SOVRIAD for Chronic hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where SOVRIAD was used for Chronic hepatitis c.
Most Reported Side Effects for SOVRIAD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Platelet count decreased | 12 | 19.1% | 4 | 5 |
| Neutrophil count decreased | 10 | 15.9% | 0 | 0 |
| Haemoglobin decreased | 9 | 14.3% | 0 | 2 |
| White blood cell count decreased | 9 | 14.3% | 0 | 3 |
| Alanine aminotransferase increased | 8 | 12.7% | 4 | 5 |
| Off label use | 8 | 12.7% | 0 | 3 |
| Aspartate aminotransferase increased | 7 | 11.1% | 4 | 4 |
| Blood bilirubin increased | 7 | 11.1% | 0 | 1 |
| Hyperbilirubinaemia | 6 | 9.5% | 3 | 3 |
| Pyrexia | 6 | 9.5% | 3 | 4 |
| Anaemia | 5 | 7.9% | 0 | 2 |
| Disseminated intravascular coagulation | 5 | 7.9% | 5 | 4 |
Other Indications for SOVRIAD
Other Drugs Used for Chronic hepatitis c
RIBAVIRIN (15,707)
PEGINTERFERON ALFA-2A (7,898)
LEDIPASVIR\SOFOSBUVIR (6,621)
SOFOSBUVIR\VELPATASVIR (6,405)
SOFOSBUVIR (6,008)
TELAPREVIR (3,103)
GLECAPREVIR\PIBRENTASVIR (3,072)
SIMEPREVIR (2,735)
DACLATASVIR (2,063)
PEGINTERFERON ALFA-2B (1,927)